Please assess the completion status of the following clinical trial:

Trial Title: PHA-739358 for the Treatment of Multiple Myeloma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* active multiple myeloma progressing after at least 2 prior lines of treatment~* measurable disease~* t(4;14) translocation~* life expectancy of at least 3 months~Exclusion Criteria:~* uncontrolled hypertension~* myocardial infarction, unstable angina, symptomatic congestive heart failure, cerebrovascular accident in the past 6 months.~* pregnancy or breast feeding~* active infections, including HIV

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).